I

Immatics NV
D

IMTX

7.59000
USD
0.00
(0.00%)
Market Closed
Volume
0
EPS
0
Div Yield
-
P/E
-12
Market Cap
922,564,925
OverviewSignalsIdeasNews
Related Instruments
    AZN
    AZN
    -1.830
    (-2.81%)
    63.220 USD
    B
    BNTX
    -3.740
    (-3.61%)
    99.740 USD
    GSK
    GSK
    -1.020
    (-2.97%)
    33.350 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    154.020 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    96.290 USD
    MRNA
    MRNA
    -2.950
    (-7.42%)
    36.830 USD
    N
    NVAX
    0.12000
    (1.67%)
    7.32500 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    24.800 USD
    REGN
    REGN
    -25.40
    (-3.25%)
    756.82 USD
    VRTX
    VRTX
    -18.53
    (-3.83%)
    465.67 USD
    More
News

Title: Immatics NV

Sector: Healthcare
Industry: Biotechnology
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.